Loading organizations...
Loading organizations...
Clinical-stage biopharmaceutical company targeting inflammatory disorders.
EpiEndo Pharmaceuticals has raised $34.0M across 2 funding rounds.
EpiEndo Pharmaceuticals has raised $34.0M in total across 2 funding rounds.
EpiEndo Pharmaceuticals has raised $34.0M in total across 2 funding rounds.
EpiEndo Pharmaceuticals's investors include Carl-Johan Spak, hilmar janusson, Ivar Gudjonsson, European Innovation Council.
EpiEndo Pharmaceuticals has raised $34.0M across 2 funding rounds. Most recently, it raised $10.5M Other Equity in January 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 7, 2026 | $10.5M Other Equity | ||
| Aug 18, 2021 | $23.5M Series A | Carl-Johan Spak, hilmar janusson | Ivar Gudjonsson, European Innovation Council |